We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.55%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$6.05B
AUM Growth
+$143M
(+2.4%)
Cap. Flow
-$206M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
48.47%
Holding
77
New
14
Increased
23
Reduced
24
Closed
12
Avg Time Held
7.3
quarters
Top 10 Avg Time Held
5.8
quarters
Top 20 Avg Time Held
6.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paramount Global Class B
PARA
|
+$160M |
| 2 |
Centene
CNC
|
+$138M |
| 3 |
Global Payments
GPN
|
+$135M |
| 4 |
Amazon
AMZN
|
+$68.6M |
| 5 |
Quantum-Si Incorporated
QSI
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$191M |
| 2 |
Cigna
CI
|
+$143M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$135M |
| 4 |
DXC Technology
DXC
|
+$120M |
| 5 |
Takeda Pharmaceutical
TAK
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.04% |
| 2 | Technology | 9.78% |
| 3 | Communication Services | 7.21% |
| 4 | Materials | 6.27% |
| 5 | Industrials | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Tenet Healthcare
THC
$21.5B
| $713M | 11.8% |
10,645,320
-3,080,000
| -22% | -$191M |
2013 Q2
32 quarters
|
|
2
Bausch Health
BHC
$2.2B
| $479M | 7.92% |
16,337,549
+724,459
| +5% | +$21.9M |
2018 Q3
11 quarters
|
|
|
3
Cigna
CI
$74.7B
| $304M | 5.04% |
1,284,353
-574,514
| -31% | -$143M |
2013 Q2
32 quarters
|
|
4
McKesson
MCK
$112B
| $283M | 4.69% |
1,482,070
-278,635
| -16% | -$53.8M |
2016 Q4
18 quarters
|
|
|
5
DXC Technology
DXC
$2.04B
| $281M | 4.65% |
7,213,329
-3,369,156
| -32% | -$120M |
2017 Q2
16 quarters
|
|
|
6
DELISTED
Paramount Global Class B
PARA
| $197M | 3.27% |
4,368,677
+3,868,677
| +774% | +$160M |
2013 Q2
32 quarters
|
|
7
Cencora
COR
$63B
| $197M | 3.26% |
1,719,316
-94,762
| -5% | -$11.2M |
2018 Q1
13 quarters
|
|
|
8
Global Payments
GPN
$21.7B
| $174M | 2.88% |
926,966
+670,100
| +261% | +$135M |
2020 Q4
2 quarters
|
|
|
9
Takeda Pharmaceutical
TAK
$59.2B
| $153M | 2.54% |
9,115,521
-6,988,701
| -43% | -$119M |
2019 Q1
9 quarters
|
|
10
Universal Health Services
UHS
$10.6B
| $148M | 2.45% |
1,009,456
-149,684
| -13% | -$22.6M |
2016 Q3
19 quarters
|
|
|
11
Centene
CNC
$34B
| $147M | 2.44% |
+2,020,967
| New | +$138M |
2021 Q2
0 quarters
|
|
12
HCA Healthcare
HCA
$99.8B
| $138M | 2.28% |
666,935
-403,525
| -38% | -$82.2M |
2013 Q2
32 quarters
|
|
13
Alphabet (Google) Class A
GOOGL
$4.33T
| $136M | 2.25% |
1,114,880
-203,800
| -15% | -$23.8M |
2015 Q4
22 quarters
|
|
14
Coca-Cola Europacific Partners
CCEP
$46.3B
| $136M | 2.24% |
2,285,833
+918,382
| +67% | +$53.6M |
2021 Q1
1 quarter
|
|
15
DELISTED
Walgreens Boots Alliance
WBA
| $121M | 2% |
2,297,540
+1,007,710
| +78% | +$54.2M |
2021 Q1
1 quarter
|
|
16
Brookdale Senior Living
BKD
$2.42B
| $116M | 1.92% |
14,707,256
-3,341,689
| -19% | -$24M |
2014 Q2
28 quarters
|
|
17
Meta Platforms (Facebook)
META
$1.94T
| $102M | 1.69% |
294,114
-197,741
| -40% | -$63.4M |
2020 Q4
2 quarters
|
|
18
Boston Scientific
BSX
$62.8B
| $99.3M | 1.64% |
2,323,016
-874,950
| -27% | -$36.8M |
2020 Q1
5 quarters
|
|
19
Corteva
CTVA
$8.91B
| $98.9M | 1.64% |
2,230,468
+819,207
| +58% | +$37.8M |
2019 Q4
6 quarters
|
|
20
DuPont de Nemours
DD
$17.5B
| $96.3M | 1.59% |
990,799
+469,868
| +90% | +$47.2M |
2020 Q4
2 quarters
|
|
21
FMC
FMC
$1.29B
| $94.4M | 1.56% |
872,557
+12,869
| +1% | +$1.49M |
2015 Q1
25 quarters
|
|
22
Baxter International
BAX
$12.9B
| $94.1M | 1.56% |
1,169,387
-208,611
| -15% | -$17.5M |
2020 Q1
5 quarters
|
|
23
Element Solutions
ESI
$9.07B
| $89.7M | 1.48% |
3,836,051
+8,783
| +0.2% | +$193K |
2016 Q3
19 quarters
|
|
|
24
Quantum-Si Incorporated
QSI
$309M
| $88.1M | 1.46% |
7,187,091
+6,150,000
| +593% | +$64.4M |
2021 Q1
1 quarter
|
|
25
Fiserv Inc
FISV
$24.8B
| $83.7M | 1.39% |
783,500
-93,947
| -11% | -$10.9M |
2019 Q3
7 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Glenview Capital Management held 77 positions worth $6.05B, up 2.4% from $5.9B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Glenview Capital Management withdrew a net $206M in Q2 2021, closing 12 positions and reducing 24 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $135M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 68% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Glenview Capital Management opened a new position in Centene worth $147M.
- Glenview Capital Management's largest Q2 2021 buy was Centene: 2,020,967 shares worth $147M.
- Glenview Capital Management added most to Paramount Global Class B in Q2 2021, an estimated $160M increase.
- Glenview Capital Management's biggest Q2 2021 reduction was Tenet Healthcare, cutting an estimated $191M.
- Glenview Capital Management fully exited Nuance Communications, Inc. in Q2 2021, selling an estimated $135M.
- Glenview Capital Management's ten largest holdings make up 48% of its $6.05B portfolio in Q2 2021.
- Glenview Capital Management opened 14 new positions and closed 12 in Q2 2021.
- Glenview Capital Management's portfolio value rose 2.4% quarter-over-quarter to $6.05B.
Based on Glenview Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.